Stock 4547 KISSEI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Kissei Pharmaceutical Co., Ltd.

Equities

4547

JP3240600001

Pharmaceuticals

Delayed Japan Exchange
Other stock markets
 05:38:19 02/05/2024 BST 		5-day change 1st Jan Change
3,635 JPY +1.11% Intraday chart for Kissei Pharmaceutical Co., Ltd. +1.82% +17.64%
03-20 Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program MT
03-19 Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023. CI

Business Summary

KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. It is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.

Number of employees: 1,359

Sales per Business

JPY in Million2022Weight2023Weight Delta
Pharmaceuticals
83.3 %
54,147 82.8 % 56,243 83.3 % +3.87%
Information Service
12.3 %
7,742 11.8 % 8,285 12.3 % +7.01%
Construction Contract
3.5 %
2,948 4.5 % 2,343 3.5 % -20.52%
Goods
0.9 %
543 0.8 % 621 0.9 % +14.36%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
100.0 %
65,381 100.0 % 67,493 100.0 % +3.23%

Managers

Managers TitleAgeSince
Mutsuo Kanzawa CEO
 Chief Executive Officer 74 31/03/76
Takahide Kitahara DFI
 Director of Finance/CFO 62 31/03/86
Yasuo Takehana PSD
 President 63 31/03/84
Shinji Kikuchi CTO
 Chief Tech/Sci/R&D Officer 63 31/03/88
Suminori Sagara BRD
 Director/Board Member 65 31/03/82
Eiichi Matsushita BRD
 Director/Board Member 65 31/03/83
Tetsu Takayama BRD
 Director/Board Member 62 31/03/85
Keiji Fukushima BRD
 Director/Board Member 68 01/04/79
Yoshio Furihata BRD
 Director/Board Member 62 31/03/84
Masaki Morozumi BRD
 Director/Board Member 68 01/04/80

Members of the board

Members of the board TitleAgeSince
Mutsuo Kanzawa CEO
 Chief Executive Officer 74 31/03/76
Hiroe Sato BRD
 Director/Board Member 72 01/04/75
Yoshio Furihata BRD
 Director/Board Member 62 31/03/84
Shigetaka Shimizu BRD
 Director/Board Member 74 31/05/14
Yasuo Takehana PSD
 President 63 31/03/84
Sayuri Uchikawa BRD
 Director/Board Member 73 31/05/20
Eiichi Matsushita BRD
 Director/Board Member 65 31/03/83
Shinji Kikuchi CTO
 Chief Tech/Sci/R&D Officer 63 31/03/88
Minoru Nomura BRD
 Director/Board Member 77 31/05/16
Suminori Sagara BRD
 Director/Board Member 65 31/03/82

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 49,311,185 32,265,747 ( 65.43 %) 4,859,912 ( 9.856 %) 65.43 %

Shareholders

NameEquities%Valuation
KISSEI PHARMACEUTICAL CO., LTD.
10.35 %
5,105,798 10.35 % 119 M ¥
DAI-ICHI LIFE HOLDINGS, INC.
4.543 %
2,240,000 4.543 % 52 M ¥
THE HACHIJUNI BANK, LTD.
4.468 %
2,203,420 4.468 % 51 M ¥
Kanzawa Co.
3.403 %
1,678,000 3.403 % 39 M ¥
Mutsuo Kanzawa
3.127 %
1,542,000 3.127 % 36 M ¥
Kissei Group Employee Stock Ownership Plan
2.612 %
1,288,000 2.612 % 30 M ¥
Nabelin Co., Ltd.
2.478 %
1,222,000 2.478 % 29 M ¥
SHIONOGI & CO., LTD.
1.854 %
914,000 1.854 % 21 M ¥
DAIICHI SANKYO CO., LTD.
1.852 %
913,000 1.852 % 21 M ¥
ONO PHARMACEUTICAL CO., LTD.
1.716 %
846,285 1.716 % 20 M ¥

Holdings

NameEquities%Valuation
CG ONCOLOGY, INC.
5.33%
 3,543,533 5.33% 155,561,099 $
ALTEOGEN INC.
1.81%
 957,590 1.81% 140,410,972 $
KISSEI PHARMACEUTICAL CO., LTD.
10.35%
 5,105,798 10.35% 119,257,298 $
SHIONOGI & CO., LTD.
0.36%
 1,077,000 0.36% 55,150,488 $
DAIICHI SANKYO CO., LTD.
0.09%
 1,734,000 0.09% 54,731,369 $
ONO PHARMACEUTICAL CO., LTD.
0.57%
 2,860,000 0.57% 46,383,223 $
JCR PHARMACEUTICALS CO., LTD.
3.79%
 4,918,000 3.79% 27,913,437 $
THE HACHIJUNI BANK, LTD.
0.64%
 3,276,402 0.64% 22,514,517 $
MIZUHO LEASING COMPANY, LIMITED
0.82%
 2,000,000 0.82% 15,355,640 $
SUZUKEN CO., LTD.
0.59%
 461,560 0.59% 14,147,654 $

Company contact information

Kissei Pharmaceutical Co., Ltd.

19-48 Yoshino

399-8710, Matsumoto

+

http://www.kissei.co.jp
address Kissei Pharmaceutical Co., Ltd.(4547)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Ratings for Kissei Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3,595 JPY
Average target price
3,833 JPY
Spread / Average Target
+6.63%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
KISSEI PHARMACEUTICAL CO., LTD. Stock Kissei Pharmaceutical Co., Ltd.
+17.64% 1.01B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+12.68% 9.06B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-12.75% 4.96B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+42.38% 4.47B
YUHAN CORPORATION Stock Yuhan Corporation
+5.23% 3.9B
INDIVIOR PLC Stock Indivior PLC
+20.51% 2.41B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-19.05% 2.41B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-28.72% 2.23B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+11.13% 2.02B
SUPERNUS PHARMACEUTICALS, INC. Stock Supernus Pharmaceuticals, Inc.
+3.94% 1.65B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4547 Stock
  4. Company Kissei Pharmaceutical Co., Ltd.